A targeted genetic test for detecting Alzheimer's disease risk genes, particularly APOE variants. This test assesses genetic predisposition to Alzheimer's disease for early intervention planning.
Manufactured by
China
HaploX Biotechnology specializes in tumor liquid biopsy and genetic big data technologies. The company operates CAP/CLIA/EMQN/NCCL certified medical laboratories equipped with advanced gene sequencing platforms. Services cover tumor management, hereditary disease screening, and infectious disease detection, serving hundreds of hospitals and research institutions across China with international operations in Hong Kong, Singapore, Japan, Europe, and North America.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Cygnus Biosciences (Beijing)Co., Ltd.
China · 4 relevant products
BioChain (Beijing) Science & Technology. Inc.
China · 2 relevant products
ADmit Therapeutics SL
Spain · 2 relevant products
STRATEC/Diatron
Germany · 1 relevant product
Suzhou Molarray Co., Ltd.
China · 1 relevant product
Coyote Bioscience Co.,Ltd
China · 2 relevant products
Singlera GENOMICS (SHANGHAI) Ltd.
China · 5 relevant products
Shenzhen Create Medical Technology Co., Ltd.
China · 2 relevant products
GENERI BIOTECH s.r.o.
Czech Republic · 5 relevant products
Wuhan YZY Medical Science and Technology Co.,Ltd.
China · 3 relevant products
47 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →8 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 104 closest product alternatives
Cygnus Biosciences (Beijing)Co., Ltd. · China
This product detects familial Alzheimer's disease risk genes to help predict family-onset Alzheimer's disease risk in individuals, identify high-risk populations, and enable early prevention and intervention measures.
BioChain (Beijing) Science & Technology. Inc. · China
Diagnostic test for early detection of cognitive impairment and neurodegenerative disease risk. This biomarker-based test supports early intervention strategies for age-related cognitive disorders. The product aligns with research collaborations in epigenetic disease markers.
ADmit Therapeutics SL · Spain
An early detection diagnostic test designed for clinical practice to identify Alzheimer's disease at preliminary stages. The test utilizes proprietary technology to support early diagnosis and patient management in clinical settings.
STRATEC/Diatron · Germany
Diagnostic test for identifying genetic disorders through molecular analysis of biological samples. The test can detect chromosomal abnormalities and inherited genetic conditions.
Cygnus Biosciences (Beijing)Co., Ltd. · China
This product detects hereditary hypercholesterolemia risk-related genes including LDLR, APOB, PCSK9, LDLRAP1, ABCG5, and ABCG8, and simultaneously screens for drug-related genes SLCO1B1 and APOE to support clinical diagnosis and assessment.
Suzhou Molarray Co., Ltd. · China
A molecular assay for the detection of specific genetic sequences or mutations in patient samples. The test is used in genetic screening, disease diagnosis, and personalized medicine applications.
Coyote Bioscience Co.,Ltd · China
A gene genotyping detection kit for simultaneous analysis of human SLCO1B1 and ApoE genes using PCR with fluorescent probe methodology. It enables genetic testing for precision medicine and disease risk assessment. Available variants: Human SLCO1B1 And ApoE Gene Genotyping Detection Kit (PCR Fluorescent Probe Method).
Singlera GENOMICS (SHANGHAI) Ltd. · China
A molecular diagnostic solution based on DNA methylation technology for identification and characterization of genetic diseases. Enables comprehensive genetic disease screening and diagnosis.
Shenzhen Create Medical Technology Co., Ltd. · China
A genetic testing product for detection and screening of myocardial infarction risk factors. This diagnostic solution helps identify patients at risk for heart attack through gene analysis.
GENERI BIOTECH s.r.o. · Czech Republic
CE IVD real-time PCR kit for detection of APOB R3500Q mutation in human genomic DNA. Supports diagnosis of familial defective apolipoprotein B-100 and lipid disorder assessment.
BioChain (Beijing) Science & Technology. Inc. · China
Epigenetic-based diagnostic test for early detection of cerebrovascular disease and stroke risk. Developed in collaboration with Beijing Tiantan Hospital, this test supports stroke prevention initiatives. The product integrates findings from a large-scale stroke cohort study.
Wuhan YZY Medical Science and Technology Co.,Ltd. · China
Gene detection products that analyze drug metabolism and efficacy based on individual genetic variations. These tests guide personalized medication selection for patients with cardiovascular and other major diseases.
92 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products